Information sur le cancer / Diagnostic et traitement / Thérapies complémentaires / Cannabis et cannabinoïdes médicaux

Borgelt LM, Franson KL, Nussbaum AM, Wang GS.. The pharmacologic and clinical effects of medical cannabis. (2013). Pharmacotherapy. 33(2):195-209. doi: 10.1002/phar.1187.

Brisbois TD, de Kock IH, Watanabe SM, Mirhosseini M, Lamoureux DC, Chasen M, MacDonald N, et al. Delta-9-tetrahydrocannabinol may palliate altered chemosensory perception in cancer patients: results of a randomized, double-blind, placebo-controlled pilot trial. (2011). Annals of Oncology. 9):2086-93. Extrait de: http://annonc.oxfordjournals.org/content/22/9/2086.full.pdf+html.

Callaghan RC, Allebeck P, Sidorchuk A.. Marijuana use and risk of lung cancer: a 40-year cohort study. (2013). Cancer Causes and Control. 24(10):1811-20. doi: 10.1007/s10552-013-0259-0.

Chakravarti B, Ravi J, Ganju RK. Cannabinoids as therapeutic agents in cancer: current status and future implications. (2014). Oncotarget. Impact Journals. 5(15):5852-72. Extrait de: http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=2233.

Cridge BJ, Rosengren RJ. Critical appraisal of the potential use of cannabinoids in cancer management. (2013). Cancer Management and Research. Dove Medical Press. 5:301-13. Extrait de: http://www.dovepress.com/critical-appraisal-of-the-potential-use-of-cannabinoids-in-cancer-mana-peer-reviewed-article-CMAR.

Duran M1, Pérez E, Abanades S, Vidal X, Saura C, Majem M, Arriola E, et al. Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. (2010). British Journal of Clinical Pharmacology. 70(5):656-63. Extrait de: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/pdf/bcp0070-0656.pdf.

Farquhar-Smith WP. Do cannabinoids have a role in cancer pain management?. (2009). Current Opinion in Supportive and Palliative Care. Wolters Kluwer. 3(1):7-13. doi: 10.1097/SPC.0b013e3283260612.

Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. (2009). Lancet. Elsevier, Inc. 374(9698): pp:1383-91. Extrait de: http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(10)60087-6.pdf.

Health Canada, Drugs and Health Products. (2016, August 11). Information on the new Access to Cannabis for Medical Purposes Regulations. Ottawa. Extrait de: https://www.canada.ca/en/health-canada/services/drugs-health-products/medical-use-marijuana/medical-use-marijuana.html.

Huang YH, Zhang ZF, Tashkin DP, Feng B, Straif K, Hashibe M. An epidemiologic review of marijuana and cancer: an update. (2015). Cancer Epidemiology, Biomarkers and Prevention. American Association for Cancer Research. 24(1):15-31.

Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. (2010). Journal of Pain and Symptom Management. Elsevier. 39(2):167-79. doi: 10.1016/j.jpainsymman.2009.06.008.

Joshi M, Joshi A, Bartter T. Marijuana and lung diseases. (2014). Current Opinion in Pulmonary Medicine. Lippincott Williams & Wilkins. 20(2):173-9. doi: 10.1097/MCP.0000000000000026.

Lynch ME, Campbell F. Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials. (2011). British Journal of Clinical Pharmacology. Wiley. 72(5):735-44. doi: 10.1111/j.1365-2125.2011.03970.x. Extrait de: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/pdf/bcp0072-0735.pdf.

Machado Rocha FC1, Stéfano SC, De Cássia Haiek R, Rosa Oliveira LM, Da Silveira DX. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis. (2008). European Journal of Cancer Care. Wiley. 17(5):431-43.

Moulin D, Boulanger A, Clark AJ, Clarke H, Dao T, Finley GA, Furlan A, et al. Pharmacological management of chronic neuropathic pain: revised consensus statement from the Canadian Pain Society. Pain Research & Management. 19(6):328-35. Extrait de: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273712/pdf/prm-19-328.pdf.

Parker LA, Rock EM, Limebeer CL. Regulation of nausea and vomiting by cannabinoids. (2011). British Journal of Pharmacology. 163(7):1411-22.

Robson PJ.. Therapeutic potential of cannabinoid medicines. (2013). Drug Testing and Analysis. Wiley. doi: 10.1002/dta.1529. (PMID: 24006213).

Rooke SE, Norberg MM, Copeland J, Swift W.. Health outcomes associated with long-term regular cannabis and tobacco smoking. (2013). Addictive Behaviours. Elsevier. 38(6):2207-13. doi: 10.1016/j.addbeh.2013.01.013.

Tramer MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA, McQuay HJ. Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review. (2001). BMJ. 323(7303):16-21.

Zhang LR, Morgenstern H, Greenland S, Chang SC, Lazarus P, Teare MD, Woll PJ, et al. Cannabis smoking and lung cancer risk: Pooled analysis in the International Lung Cancer Consortium. (2015). International Journal of Cancer. Wiley. 136(4):894-903. doi: 10.1002/ijc.29036.